Long term study of chlormethine gel for mycosis fungoides
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how well chlormethine gel works over time for people with mycosis fungoides, a type of skin lymphoma. It is for patients who started this gel treatment between 2019 and 2024.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with mycosis fungoides, a type of lymphoma that affects the skin
- You started treatment with chlormethine gel between September 2019 and September 2024
- You have been on this treatment for at least 6 months
- Your medical records are available and complete
- You can read and write in Italian
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at the results of different systemic (whole-body) treatments for cutaneous T-cell lymphoma (CTCL), a rare type of lymphoma that affects the skin. It aims to understand how well these therapies work and help guide future treatment choices.
This trial is testing new treatment plans based on the genetic type of your cutaneous T-cell lymphoma (CTCL). It's for people whose CTCL did not respond well to standard skin treatments.
This trial tests a combination of two drugs for people with a specific type of skin lymphoma. Brentuximab vedotin targets a protein called CD30 on lymphoma cells, and lisaftoclax helps destroy those cells. The goal is to see if this combination is safe and effective.
This study tests a cream called benvitimod to see if it helps treat cutaneous T-cell lymphoma, a type of skin lymphoma. It is for adults who have already been diagnosed with this condition.
This study tests whether a special skin care body wash can improve skin lesions in people with mycosis fungoides, a type of skin lymphoma. Researchers will look at skin bacteria before and after using the wash.
This trial tests a cream applied to the skin that may help control early-stage mycosis fungoides, a type of skin lymphoma. It aims to see if the cream can reduce symptoms and slow disease progression without the need for stronger treatments.
Hear when a new Cutaneous T-Cell Lymphoma/Mycosis Fungoides trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.